Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Indications for both host-specific and introduced genotypes of Staphylococcus aureus in marine mammals.

van Elk CE, Boelens HA, van Belkum A, Foster G, Kuiken T.

Vet Microbiol. 2012 May 4;156(3-4):343-6. doi: 10.1016/j.vetmic.2011.10.034. Epub 2011 Nov 6.

PMID:
22112853
2.

Rhesus macaques (Macaca mulatta) are natural hosts of specific Staphylococcus aureus lineages.

van den Berg S, van Wamel WJ, Snijders SV, Ouwerling B, de Vogel CP, Boelens HA, Willems RJ, Huijsdens XW, Verreck FA, Kondova I, Heidt PJ, Verbrugh HA, van Belkum A.

PLoS One. 2011;6(10):e26170. doi: 10.1371/journal.pone.0026170. Epub 2011 Oct 20. Erratum in: PLoS One. 2012;7(8). doi: 10.1371/annotation/bc0581bd-5ef5-4116-b3b6-6fc6c5eb197c.

3.

Immune evasion cluster-positive bacteriophages are highly prevalent among human Staphylococcus aureus strains, but they are not essential in the first stages of nasal colonization.

Verkaik NJ, Benard M, Boelens HA, de Vogel CP, Nouwen JL, Verbrugh HA, Melles DC, van Belkum A, van Wamel WJ.

Clin Microbiol Infect. 2011 Mar;17(3):343-8. doi: 10.1111/j.1469-0691.2010.03227.x.

4.

Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia.

Verkaik NJ, Boelens HA, de Vogel CP, Tavakol M, Bode LG, Verbrugh HA, van Belkum A, van Wamel WJ.

Eur J Clin Microbiol Infect Dis. 2010 May;29(5):509-18. doi: 10.1007/s10096-010-0888-0. Epub 2010 Feb 26.

5.

Reclassification of Staphylococcus aureus nasal carriage types.

van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Wertheim HF.

J Infect Dis. 2009 Jun 15;199(12):1820-6. doi: 10.1086/599119.

PMID:
19419332
6.

Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.

Verkaik NJ, de Vogel CP, Boelens HA, Grumann D, Hoogenboezem T, Vink C, Hooijkaas H, Foster TJ, Verbrugh HA, van Belkum A, van Wamel WJ.

J Infect Dis. 2009 Mar 1;199(5):625-32. doi: 10.1086/596743.

PMID:
19199541
7.

Host-microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients.

Melles DC, Pauw E, van den Boogaard L, Boelens HA, Peters J, Peeters JK, Witsenboer H, van Leeuwen WB, Verbrugh HA, van Belkum A, Nouwen JL.

Microbes Infect. 2008 Feb;10(2):151-8. doi: 10.1016/j.micinf.2007.10.017. Epub 2007 Nov 9.

PMID:
18248760
8.

Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans.

Wertheim HF, Walsh E, Choudhurry R, Melles DC, Boelens HA, Miajlovic H, Verbrugh HA, Foster T, van Belkum A.

PLoS Med. 2008 Jan 15;5(1):e17. doi: 10.1371/journal.pmed.0050017.

9.

Panton-Valentine leukocidin genes in Staphylococcus aureus.

Melles DC, van Leeuwen WB, Boelens HA, Peeters JK, Verbrugh HA, van Belkum A.

Emerg Infect Dis. 2006 Jul;12(7):1174-5. No abstract available.

10.

Perianal fistulas in Crohn's disease are predominantly colonized by skin flora: implications for antibiotic treatment?

West RL, Van der Woude CJ, Endtz HP, Hansen BE, Ouwedijk M, Boelens HA, Kusters JG, Kuipers EJ.

Dig Dis Sci. 2005 Jul;50(7):1260-3.

PMID:
16047469
11.

Host- and tissue-specific pathogenic traits of Staphylococcus aureus.

van Leeuwen WB, Melles DC, Alaidan A, Al-Ahdal M, Boelens HA, Snijders SV, Wertheim H, van Duijkeren E, Peeters JK, van der Spek PJ, Gorkink R, Simons G, Verbrugh HA, van Belkum A.

J Bacteriol. 2005 Jul;187(13):4584-91.

12.

Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.

Wertheim HF, Verveer J, Boelens HA, van Belkum A, Verbrugh HA, Vos MC.

Antimicrob Agents Chemother. 2005 Apr;49(4):1465-7.

13.

Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus.

Melles DC, Gorkink RF, Boelens HA, Snijders SV, Peeters JK, Moorhouse MJ, van der Spek PJ, van Leeuwen WB, Simons G, Verbrugh HA, van Belkum A.

J Clin Invest. 2004 Dec;114(12):1732-40.

14.

Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule".

Nouwen JL, Ott A, Kluytmans-Vandenbergh MF, Boelens HA, Hofman A, van Belkum A, Verbrugh HA.

Clin Infect Dis. 2004 Sep 15;39(6):806-11. Epub 2004 Aug 26.

PMID:
15472812
15.

Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use.

Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, Kluytmans JA, van Keulen PH, Verbrugh HA.

J Hosp Infect. 2004 Apr;56(4):321-5.

PMID:
15066745
16.

Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state.

VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA.

J Clin Microbiol. 1999 Oct;37(10):3133-40.

17.

Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus.

Yzerman EP, Boelens HA, Vogel M, Verbrugh HA.

J Antimicrob Chemother. 1998 Aug;42(2):233-9.

PMID:
9738842
18.

Delta APACHE II for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defense.

Yzerman EP, Boelens HA, Tjhie JH, Kluytmans JA, Mouton JW, Verbrugh HA.

J Infect Dis. 1996 Apr;173(4):914-9.

PMID:
8603971

Supplemental Content

Loading ...
Support Center